Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04361136
PHASE1

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

Sponsor: LEO Pharma

View on ClinicalTrials.gov

Summary

This is a single-centre, randomised, vehicle-controlled, double-blind, within-subject comparison phase 1 clinical trial. The trial is designed to find out if delgocitinib cream can cause skin irritation after light exposure in people with healthy skin.

Official title: A Phase 1 Clinical Trial to Evaluate the Phototoxic Potential of Delgocitinib Cream After Single Topical Occlusive Application on Healthy Skin

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

35

Start Date

2020-04-23

Completion Date

2020-05-30

Last Updated

2026-04-28

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Delgocitinib cream

Cream for topical application

DRUG

Delgocitinib cream vehicle

The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.

Locations (1)

Bioskin Research Center Dermatology

Hamburg, Germany